These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7382773)

  • 1. [Use of 5-fluorouracil in the radiation therapy of cervical cancer].
    Gerinshteĭn IG; Kislichenko VA; Tarkhanova MV; Pashchenko NS; Kolesnikova GS
    Med Radiol (Mosk); 1980 May; 25(5):33-7. PubMed ID: 7382773
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mitotic index as a criterion of the effectiveness of the radiation therapy of human tumors].
    Gubareva AV
    Med Radiol (Mosk); 1979 Dec; 24(12):26-9. PubMed ID: 513994
    [No Abstract]   [Full Text] [Related]  

  • 3. [Postoperative simultaneous radiochemotherapy improves survival in patients with cervical carcinoma].
    Dunst J
    Strahlenther Onkol; 2000 Oct; 176(10):486-7. PubMed ID: 11068599
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.
    Gasinska A; Fowler JF; Lind BK; Urbanski K
    Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
    Dunst J; Haensgen G
    Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer.
    Kawase S; Okuda T; Ikeda M; Ishihara S; Itoh Y; Yanagawa S; Ishigaki T
    Gynecol Oncol; 2006 Sep; 102(3):493-9. PubMed ID: 16478629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant oral 5-fluorouracil for cervical cancer: Japanese Gynecologic Oncology Group report.
    Yamamoto K; Izumi R; Hasegawa K; Nakajima H; Ohashi K; Kudo R; Okuda H; Takahashi T; Origasa H; Sugimori H
    Int J Oncol; 2004 May; 24(5):1175-9. PubMed ID: 15067339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.
    Windschall A; Ott OJ; Sauer R; Strnad V
    Strahlenther Onkol; 2005 Aug; 181(8):545-50. PubMed ID: 16044224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
    Husseinzadeh N; Shrake P; DeEulis T; Rowley K; Aron B
    Gynecol Oncol; 1994 Mar; 52(3):326-31. PubMed ID: 8157190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic radiation-induced variations in cellular radiosensitivity in a mouse mammary tumor.
    Rockwell S; Kallman RF
    Radiat Res; 1974 Jan; 57(1):132-47. PubMed ID: 10874932
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer.
    Thomas G; Dembo A; Ackerman I; Franssen E; Balogh J; Fyles A; Levin W
    Gynecol Oncol; 1998 May; 69(2):137-45. PubMed ID: 9600821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic p105 index is an accurate mitotic index, but is not related to prognosis in cervical carcinoma.
    Oka K; Nakano T; Arai T
    Arch Pathol Lab Med; 1994 May; 118(5):506-9. PubMed ID: 7910727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
    Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O
    Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change in the phagocytic activity of leukocytes in patients with cancer of the cervix uteri undergoing radiotherapy].
    Sokolova NM; Klechikov LZ; Saridzhalinskaia EK
    Vopr Onkol; 1966; 12(6):32-5. PubMed ID: 6000102
    [No Abstract]   [Full Text] [Related]  

  • 16. Apoptotic index as predictive marker for radiosensitivity of cervical carcinoma: evaluation of membrane fluidity, biochemical parameters and apoptosis after the first dose of fractionated radiotherapy to patients.
    Bhosle SM; Huilgol NG; Mishra KP
    Cancer Detect Prev; 2005; 29(4):369-75. PubMed ID: 16125335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in cell age cohort composition of tumors and normal tissues by radiation and chemotherapy.
    Maruyama Y; Feola J
    Rev Interam Radiol; 1976 Jul; 1(1):1-7. PubMed ID: 1027055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of mitotic index of proliferating cell populations in cervical cancer patients treated with carbon ion beam.
    Suzuki Y; Oka K; Ohno T; Kato S; Tsujii H; Nakano T
    Cancer; 2009 May; 115(9):1875-82. PubMed ID: 19224551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of second cancers after radiotherapy for cervical cancer.
    Ohno T; Kakinuma S; Kato S; Tsujii H; Shimada Y
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):49-57. PubMed ID: 16375644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early clinical experience with radiation therapy of the advanced tumors following synchronization of the cell cycle with 5-fluorouracil.
    Marzecki Z; Krygier-Stojalowska A; Zaborek B; Mietkiewski J; Meyer A; Mazuryk R; Torbé Z
    Radiobiol Radiother (Berl); 1980; 21(4):417-23. PubMed ID: 7455024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.